1. 2SPD-007 Comparative effectiveness and safety of everolimus and axitinib as second-line therapy in metastatic renal cell carcinoma. (2nd March 2018) Authors: Collado-Borrell, R; Escudero-Vilaplana, V; Ortega-Navarro, C; García-Martín, E; Herranz-Alonso, A; Sanjurjo-Saez, M Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 3PC-023 A risk analysis method to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safety. (March 2019) Authors: Marzal Alfaro, B; Rodríguez-González, CG; Escudero-Vilaplana, V; Revuelta-Herrero, JL; Ibáñez-Garcia, S; García Martín, E; González-Haba, E; Iglesias-Peinado, I; Herranz, A; Sanjurjo-Saez, M Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 4CPS-168 Postoperative pain management and pain referred by adult patients 24 hours after surgery and one month after discharge. (March 2019) Authors: Martinez Ortega, P; Gimenez-Manzorro, A; Ribed-Sanchez, A; de Lorenzo-Pinto, A; Garcia-Martin, E; Garcia-Sanchez, S; Amor-Garcia, MA; Garcia-Moreno, FJ; Melgarejo-Ortuño, A; Herranz-Alonso, A; Sanjurjo-Saez, M Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 5PSQ-033 Effectiveness of computerised decision support system-based intervention in antimicrobial use: the HIGEA project. (March 2019) Authors: Rodriguez-Gonzalez, CG; Chamorro-de Vega, E; Ibañez-Garcia, S; Martin-Barbero, ML; de la Rosa, JL; Herranz-Alonso, A; Sanjurjo-Saez, M Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 5PSQ-048 Analysis of drug interactions between oral antineoplastic agents and concurrent medications. (24th March 2020) Authors: Narrillos-Moraza, A; Escudero-Vilaplana, V; Collado-Borrell, R; Hoyo-Muñoz, A; Gimenez-Manzorro, A; Amor-Garcia, MA; Osorio-Prendes, S; Calles-Blanco, A; Herranz-Alonso, A; Sanjurjo-Saez, M Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. 5PSQ-067 Analysis of antineoplastic drugs preparation errors as a first step to improve the quality of the process. (2nd March 2018) Authors: Alfaro, B Marzal; Escudero-Vilaplana, V; Rodríguez-González, CG; Peña, E González-Haba; García-González, X; Ibañez-García, S; García-Moreno, FJ; Ortega-Navarro, C; Iglesias-Peinado, I; Herranz, A; Sanjurjo-Saez, M Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 5PSQ-070 Safety strategies to improve drug labelling in operating rooms. (24th March 2020) Authors: Melgarejo-Ortuño, A; Ribed-Sánchez, A; Bermejo-Albares, ML; García-García, A; Giménez-Manzorro, Á; Amor-García, MÁ; Narrillos-Moraza, Á; García-Sánchez, S; García-Moreno, F; Herranz-Alonso, A; Sanjurjo-Saez, M Journal: European journal of hospital pharmacy Issue: Volume 27(2020)Supplement 1 Page Start: A182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 5PSQ-083 Four years of a pharmaceutical care programme in patients undergoing cardiac surgery. Issue 1 (23rd March 2023) Authors: Cavada Carranza, I; García-González, X; Ibáñez-García, S; Gómez-Costas, D; Herranz-Alonso, A; Sanjurjo-Saez, M Journal: European journal of hospital pharmacy Issue: Volume 30:Issue 1(2023)supplement 1 Page Start: A140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 6ER-007 Off-label use of dalbavancin in gram-positive infections: effectiveness, safety and cost in clinical practice. (March 2019) Authors: Chamorro-De Vega, E; Rodriguez-Gonzalez, CG; Rochet, ME; Valerio, M; Olmedo, M; Herranz-Alonso, A; Munoz, P; Sanjurjo-Saez, M Journal: European journal of hospital pharmacy Issue: Volume 26(2019)Supplement 1 Page Start: A280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CP-005 Association between medication adherence and effectiveness in the use of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome. (14th February 2016) Authors: Escudero-Vilaplana, V; Mejias-Gomez, O; de la Encina, J Leal; Osorio-Prendes, S; Garcia-Gonzalez, X; Romero-Jimenez, RM; Rodriguez-Gonzalez, CG; Tovar-Pozo, M; Herranz-Alonso, A; Sanjurjo-Saez, M Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗